Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: Results of a randomized controlled trial with 1-year follow-up

Dermatologic Surgery

Volumn 33, Issue 3, 2007, Pages 276-281

  Ceulen, Roeland P M ^a   Bullens Goessens, Yolande I J M ^a   Pi Van De Venne, Sebastien J A ^a   Nelemans, Patty J ^b   Veraart, Joep C J M ^a   Sommer, Anja ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; POLIDOCANOL;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN; SCLEROTHERAPY; STATISTICAL SIGNIFICANCE; VEIN INSUFFICIENCY;

FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; SAPHENOUS VEIN; SCLEROTHERAPY; TISSUE ADHESIVES; VENOUS INSUFFICIENCY;

EID: 33847262465     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33062.x     Document Type: Article

References (25)

1. Rigby KA, Palfreyman SJ, Beverley C, Michaels JA. Surgery versus sclerotherapy for the treatment of varicose veins. Cochrane Database Syst Rev 2004;(4):CD004980.
2. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-22; discussion 722.
3. Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5; discussion 1175.
4. Beebe HG, Bergan JJ, Bergqvist D, et al. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Eur J Vasc Endovasc Surg 1996;12:487-91; discussion 491-2.
5. Labropoulos N, Delis K, Nicolaides AN, et al. The role of the distribution and anatomic extent of reflux in the development of signs and symptoms in chronic venous insufficiency. J Vasc Surg 1996;23:504-10.
6. Bullens-Goessens YI, Heij JF, Veraart JC. Favorable results with duplex-guided compression sclerotherapy for varices of the small saphenous vein; a retrospective study. Ned Tijdschr Geneeskd 2003;147:117-20.
7. Cabrera J, Cabrera JJ, Garcia Olemedo M. Treatment of varicose long saphenous veins with sclerosants in microfoam: long term outcomes. Phlebology 2000;15:19-23.
8. McAusland S. The modern treatment of varicose veins. Med Press Circular 1939;201:404-10.
9. Orbach E. Sclerotherapy of varicose veins-utilisation of an intravenous air block. Am J Surg 1944;3:362-6.
10. Hobbs JT. Surgery and sclerotherapy in the treatment of varicose veins: a random trial. Arch Surg 1974;109:793-6.
11. Rutgers PH, Kitslaar PJ. Randomized trial of stripping versus high ligation combined with sclerotherapy in the treatment of the incompetent greater saphenous vein. Am J Surg 1994;168:311-5.
12. Kahle B, Leng K. Efficacy of sclerotherapy in varicose veins-prospective, blinded, placebo-controlled study. Dermatol Surg 2004;30:723-8; discussion 728.
13. Wollmann JC. The history of sclerosing foams. Dermatol Surg 2004;30:694-703; discussion 703.
14. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-5; discussion 635.
15. Rao J, Goldman MP. Stability of foam in sclerotherapy. Differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg 2005;31:19-22.
16. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8.
17. Breu F, Marshall M, Gugggenbichler S. Prospektive untersuchungen zur schaumsklerosierung: die erste drei Jahre. Vasomed 2005;17:20.
18. Belcaro G, Nicolaides AN, Ricci A, et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10-year follow-up trial-final results. Angiology 2000;51:529-34.
19. Demagny A. Étude comparative de l'efficacité dún produit sclérosant sous ses formes lipuide ou mousse dans la sclérose echoguidée des crosses de grandes et petites veines saphénes. Phlebologie 2002;55:133-7.
20. Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg 2005;18:19-24.
21. Breu F, Gugggenbichler S, Marshall M. Konsensus und eigene Erfahrungen zur Schaumverödung. Vasomed 2004;16:25.
22. Einarsson E, Eklof B, Neglen P. Sclerotherapy or surgery as treatment for varicose veins: a prospective randomized study. Phlebology 1993;8:22-6.
23. Jakobsen B. The value of different forms of treatment for varicose veins. Br J Surg 1979;66:182-4.
24. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (aethoxysklerol) study: results at 2 years. Dermatol Surg 1995;21:334-6; discussion 337-8.
25. Hobbs Surgery or sclerotherapy for varicose veins. Lancet 1978;1:1149.